News and Opinions - World Stem Cell Summit

2024 Annual World Congress – Society of Brain Mapping & Therapeutics

by admin | Mar 12, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

MARCH 14 – 17, 2024 The program will represent state-of-the-art science and technology in the field of neuroscience, engineering, neurosurgery, psychiatry, psychology, molecular biology, neurology, radiology and oncology. Melissa King organized the regenerative...

Brad Inman, Creator of Livelong Summit and Bernie Siegel, founder of HSAC, discuss the Livelong Summit happening March 15-16 in Palm Beach, FL

by admin | Mar 11, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Watch the recorded LinkedIn Video – Click Here In this video Bernie & Brad discuss the life-changing Livelong Summit coming to Palm Beach Convention Center on March 15 & 16, sponsored by the Healthspan Action Coalition. To learn more & to register...

MEGA-CRISPR tool gives a power boost to cancer-fighting cells

by admin | Mar 8, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Sara Reardon – Nature – The CRISPR–Cas9 gene-editing system excels at altering and disrupting genes. But the changes it makes are permanent, which can be a big problem if the system goes awry. Now, a CRISPR-based system that targets a cell’s short-lived...

US biotech fundraising boom ends 2-year deal drought

by admin | Mar 7, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Nicholas Megaw – Fianacial Times – Biotech companies are rushing to raise money in US equity markets at the fastest rate since the peak of the mid-pandemic market boom. Drug developers raised $6.2bn in equity capital markets in January, according to...

Gene Signature May Predict Response to Immunotherapy for Non-Small Cell Lung Cancer

by admin | Mar 6, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Weill Cornell Medicine – A new study identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small cell lung cancer (NSCLC) treated with a combination of immunotherapy and low-dose radiation. The results,...

FDA approves first cell therapy for solid tumors

by admin | Mar 5, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Megan Giboney – RegMedNet – The US FDA has granted accelerated approval for AMTAGVI™ (lifileucel), a novel cell therapy for advanced melanoma. This is the first cell therapy to be approved by the FDA for the treatment of a solid tumor. AMTAGVI utilizes...